MC1R
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
05.04.2016
Fat tissue in energy saving mode
Scientists at the Max Planck Institute for Metabolism Research in Cologne have discovered brain cells, which not only tell hungry mice to search for food, but also to limit blood […]
11.02.2019
TEOXANE Wins Award for Best Injectable Treatment at 2018 Aesthetics Awards
TEOXANE Laboratories is proud to announce that its Hyaluronic acid dermal filler, TEOSYAL®RHA, has been recognised at the prestigious Aesthetics Awards as the leading injectable treatment of 2018. The much […]